Business Context and Reporting Period
This Form 8-K filing by Concentra Group Holdings Parent, Inc. (Concentra) reports on events occurring on November 25, 2024. The filing documents the completion of a previously announced spin-off from Select Medical Holdings Corporation (Select), resulting in Concentra becoming an independent publicly traded company.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on the corporate transaction details of the spin-off.
Material Changes
- Change in Control: Select Medical Holdings Corporation completed the distribution of 104,093,503 shares of Concentra common stock to its stockholders as of the November 18, 2024 record date.
- Ownership Structure: Prior to the distribution, Select owned approximately 81.7% of Concentra's outstanding shares. Following the distribution, Select no longer owns any shares of Concentra.
- Distribution Ratio: Select stockholders received 0.806971 shares of Concentra common stock for every share of Select common stock held. Fractional shares were settled in cash.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond the structural change of the spin-off. It references a press release (Exhibit 99.1) for further details on the completion of the distribution.
Investor Verification Checklist
- Verify the trading status of Concentra common stock (Symbol: CON) on the New York Stock Exchange post-spin-off.
- Confirm the cash settlement amount received for fractional shares if applicable to your holdings.
- Review the attached press release (Exhibit 99.1) for additional details on the separation agreement and initial capital structure.
- Monitor subsequent filings (e.g., 10-K or 10-Q) for the first standalone financial results of Concentra.